Trinity College, Dublin Gets E20m For Nanotechnology - News Item

A facility in Trinity College Dublin developing nanotechnolgies for use in the medical and ICT sectors, has been awarded more than E20m.

Half of the funding will go to a nanoscience research facility, and the rest to a centre to develop next generation microelectronics and new drug delivery systems.

Posted 12th January 2004

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Trinity College Dublin. (2013, June 11). Trinity College, Dublin Gets E20m For Nanotechnology - News Item. AZoNano. Retrieved on December 05, 2024 from https://www.azonano.com/article.aspx?ArticleID=404.

  • MLA

    Trinity College Dublin. "Trinity College, Dublin Gets E20m For Nanotechnology - News Item". AZoNano. 05 December 2024. <https://www.azonano.com/article.aspx?ArticleID=404>.

  • Chicago

    Trinity College Dublin. "Trinity College, Dublin Gets E20m For Nanotechnology - News Item". AZoNano. https://www.azonano.com/article.aspx?ArticleID=404. (accessed December 05, 2024).

  • Harvard

    Trinity College Dublin. 2013. Trinity College, Dublin Gets E20m For Nanotechnology - News Item. AZoNano, viewed 05 December 2024, https://www.azonano.com/article.aspx?ArticleID=404.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.